Baillie Gifford & Co. Lowers Holdings in Mettler-Toledo International Inc. (NYSE:MTD)

Baillie Gifford & Co. trimmed its position in Mettler-Toledo International Inc. (NYSE:MTDFree Report) by 46.4% in the 3rd quarter, Holdings Channel reports. The firm owned 97,005 shares of the medical instruments supplier’s stock after selling 84,123 shares during the quarter. Baillie Gifford & Co.’s holdings in Mettler-Toledo International were worth $145,478,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in MTD. Family Firm Inc. purchased a new position in Mettler-Toledo International in the 2nd quarter worth approximately $25,000. Blue Trust Inc. boosted its holdings in shares of Mettler-Toledo International by 242.9% in the 3rd quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock worth $34,000 after purchasing an additional 17 shares in the last quarter. Ashton Thomas Securities LLC bought a new position in shares of Mettler-Toledo International during the 3rd quarter valued at about $37,000. Rothschild Investment LLC purchased a new position in shares of Mettler-Toledo International during the 2nd quarter valued at about $42,000. Finally, Itau Unibanco Holding S.A. bought a new stake in Mettler-Toledo International in the 2nd quarter worth approximately $42,000. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts have commented on the stock. Wells Fargo & Company decreased their price target on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research note on Monday. Robert W. Baird lowered their price target on shares of Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating for the company in a research note on Monday. JPMorgan Chase & Co. lifted their price objective on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the stock a “neutral” rating in a report on Monday, August 5th. Evercore ISI raised their price target on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 1st. Finally, Stifel Nicolaus lowered their price objective on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat, Mettler-Toledo International has a consensus rating of “Hold” and an average price target of $1,338.75.

Check Out Our Latest Research Report on MTD

Insider Buying and Selling

In other Mettler-Toledo International news, insider Christian Magloth sold 1,000 shares of Mettler-Toledo International stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $1,422.97, for a total transaction of $1,422,970.00. Following the completion of the transaction, the insider now owns 734 shares in the company, valued at approximately $1,044,459.98. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.94% of the stock is owned by company insiders.

Mettler-Toledo International Price Performance

Shares of NYSE MTD opened at $1,250.07 on Tuesday. Mettler-Toledo International Inc. has a 1 year low of $1,015.29 and a 1 year high of $1,546.93. The stock has a market capitalization of $26.53 billion, a P/E ratio of 33.70, a P/E/G ratio of 3.83 and a beta of 1.16. The company’s 50-day moving average is $1,394.23 and its 200 day moving average is $1,402.64.

Mettler-Toledo International (NYSE:MTDGet Free Report) last announced its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.00 by $0.21. The firm had revenue of $954.54 million during the quarter, compared to analyst estimates of $941.93 million. Mettler-Toledo International had a negative return on equity of 532.25% and a net margin of 21.15%. Research analysts anticipate that Mettler-Toledo International Inc. will post 40.34 earnings per share for the current year.

Mettler-Toledo International Company Profile

(Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Recommended Stories

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International Inc. (NYSE:MTDFree Report).

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.